-
05/01/2009
'Levelling' the spread of malaria
-
02/01/2009
Blood-screening product given US approval
-
09/01/2009
Doctor-to-patient HIV transmission unlikely, say US experts
-
07/01/2009
Europe-wide surge in measles cases
-
06/01/2009
Gel doesn't protect against HIV
-
05/01/2009
Giving HIV 'the shoe'
-
08/01/2009
GP body launches flu guidance
-
09/01/2009
GPs urged to prepare for flu pandemic
-
08/01/2009
HIV figures distorted by varying susceptibility
-
08/01/2009
Judge issues deadline for hepatitis death answers
-
09/01/2009
Kenyan malaria drug supply 'secure'
-
09/01/2009
Measles on the rise in London
-
09/01/2009
More Africans acquiring HIV in UK than previously thought
-
05/01/2009
Mosquito bacteria could 'limit' dengue impact
-
06/01/2009
New bird flu cases after six year absence
-
07/01/2009
NHS set for "rollercoaster" flu season
-
06/01/2009
Special bacteria engineered to cut mosquito lifespans
-
07/01/2009
US authority green lights new AIDS screening method
HIV vaccine awaiting federal approval
The makers of a new drug are waiting for approval from the US Food and Drug Administration to run phase two trials of its HIV vaccine.
Biotechnology firm GeoVax Labs has been developing the vaccine with Emory University, the Centre for Disease Control and the National Institute of Health.
The Atlanta Journal-Constitution reports that a previous trial on monkeys suppressed the Aids infection in the animals without the need for any additional drugs.
GeoVax now hopes to get the go-ahead for a human study involving over 200 "health volunteers" to "further evaluate the safety" of the vaccine.
Harriet Robinson, co-founder of GeoVax, told the newspaper she had not "anticipated the extent of vaccine control that was achieved in the already infected nonhuman primates", calling the results "highly promising".
A new institute to monitor the development of new HIV drugs was recently announced.
The National Institute of Allergy and Infectious Diseases has formed the new Vaccine Discovery Branch as part of its Vaccine Research Programme in the Division of Aids.
Send this article to a friend
Comment on this article
Bookmark this video